Thalidomide 4'-ether-alkylC2-amine hydrochloride is primarily utilized in research settings for its potential therapeutic properties, particularly in the field of oncology and immunology. It is studied for its ability to modulate the immune system and inhibit angiogenesis, which is the process of new blood vessel formation. This makes it a candidate for the treatment of certain cancers, as cutting off the blood supply to tumors can hinder their growth and spread. Additionally, its immunomodulatory effects are being explored in autoimmune diseases, where it may help regulate the overactive immune response. Researchers are also investigating its potential in treating inflammatory conditions due to its ability to influence cytokine production. Its application in these areas is still under investigation, with a focus on optimizing its efficacy and minimizing adverse effects.